Dr. Reddy's Laboratories Ltd (RDY) Financial Statements
$13.21NYSE: RDYMarket Cap $11.00B
Dr. Reddy's Laboratories Ltd most recently reported annual revenue of $353.5B, net profit of $45.1B. Revenue grew at an average annual rate of 168.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Dr. Reddy's Laboratories Ltd: Revenue rose from $140.8B in 2017 to $353.5B in 2026, a change of +151.0% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 9.6% to 13.8%, a shift of +4.2 percentage points; the most recent year shows net profit of $45.1B.
Income Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Revenue
$140.8B
$142.0B
$153.9B
$174.6B
$2.6B
$214.4B
$245.9B
$279.2B
$325.5B
$353.5B
Operating Expenses
$127.3B
$130.1B
$133.0B
$158.6B
$2.1B
$184.9B
$188.7B
$211.4B
$253.7B
$304.6B
Operating Profit
$13.5B
$11.9B
$20.9B
$16.0B
$431.0M
$29.5B
$57.1B
$67.7B
$71.8B
$48.9B
Operating Margin
9.6%
8.4%
13.6%
9.2%
16.9%
13.8%
23.2%
24.3%
22.1%
13.8%
Other Income
$1.2B
$2.4B
$1.6B
$2.0B
$-76.0M
$2.8B
$3.2B
$4.1B
$4.9B
$8.8B
Interest
$634.0M
$788.0M
$889.0M
$14.0M
$970.0M
$958.0M
$1.4B
$1.7B
$2.8B
$3.9B
Depreciation
$11.3B
$11.7B
$12.2B
$12.5B
$172.0M
$11.8B
$12.6B
$14.8B
$17.1B
$21.7B
Profit Before Tax
$14.7B
$14.3B
$22.4B
$18.0B
$356.0M
$32.3B
$60.4B
$71.9B
$76.8B
$57.7B
Tax
$17.8M
$31.6M
$16.3M
$-8.1M
$34.7M
$27.0M
$25.3M
$22.5M
$25.4M
$22.5M
Net Profit
$12.0B
$9.8B
$18.8B
$19.5B
$232.0M
$23.6B
$45.1B
$55.7B
$56.5B
$45.1B
EPS
$72.09
$59.01
$113.09
$117.40
$20.73
$28.34
$54.17
$66.80
$67.77
$53.92
Dividend Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
$832.0M
$72.1B
$70.8B
$76.7B
$80.2B
$83.6B
$85.1B
$85.5B
$88.1B
$87.3B
$76.3B
$81.2B
Operating Expenses
$656.0M
$54.9B
$55.9B
$58.8B
$62.6B
$64.9B
$67.4B
$68.0B
$70.5B
$73.0B
$75.9B
$78.2B
Operating Profit
$176.0M
$17.3B
$15.0B
$17.9B
$17.6B
$18.7B
$17.6B
$17.5B
$17.5B
$14.2B
$473.0M
$3.0B
Operating Margin
21.1%
23.9%
21.1%
23.4%
21.9%
22.4%
20.8%
20.4%
19.9%
16.3%
0.6%
3.7%
Interest
$353.0M
$394.0M
$593.0M
$598.0M
$757.0M
$818.0M
$656.0M
$830.0M
$907.0M
$952.0M
$1.1B
$1.3B
Profit Before Tax
$231.0M
$18.3B
$16.0B
$18.8B
$19.2B
$18.7B
$20.1B
$19.0B
$18.4B
$15.4B
$2.0B
$5.6B
Tax
$22.6M
$24.5M
$18.4M
$26.0M
$30.0M
$25.1M
$20.9M
$26.0M
$22.3M
$22.9M
$-10.8M
$21.3M
Net Profit
$179.0M
$13.8B
$13.1B
$13.9B
$12.6B
$14.1B
$15.9B
$14.2B
$14.4B
$12.1B
$2.2B
$4.5B
EPS
$17.76
$16.54
$15.67
$16.69
$15.05
$16.94
$19.10
$17.02
$17.25
$14.52
$2.68
$5.35
Over the 10 years reported for Dr. Reddy's Laboratories Ltd, borrowings increased from $49.2B in 2017 to $75.8B in 2026, cash stood at $15.1B in the latest year, shareholders' equity was $818.0M, current assets covered current liabilities 1.80 times.
Balance Sheet — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
$219.8B
$225.6B
$225.4B
$3.1B
$3.6B
$292.8B
$321.9B
$387.5B
$493.0B
$567.9B
Current Assets
$100.4B
$109.6B
$114.5B
$1.7B
$2.0B
$181.9B
$204.3B
$248.0B
$250.1B
$296.0B
Cash
$18.1B
$2.6B
$2.2B
$27.0M
$203.0M
$14.9B
$5.8B
$7.1B
$14.7B
$15.1B
Inventory
$28.5B
$29.1B
$33.6B
$464.0M
$621.0M
$50.9B
$48.7B
$63.6B
$71.1B
$75.0B
Receivables
$45.7B
$50.2B
$46.6B
$816.0M
$844.0M
$80.3B
$83.2B
$95.3B
$109.8B
$99.2B
Fixed Assets
$57.2B
$57.9B
$54.1B
$692.0M
$781.0M
$62.2B
$66.5B
$76.9B
$97.8B
$113.6B
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$6.8B
$23.0B
$25.9B
$377.0M
$386.0M
$37.5B
$61.4B
$79.6B
$58.5B
$87.1B
Other Assets
$3.8B
$3.9B
$3.9B
$53.0M
$62.0M
$4.4B
$4.2B
$4.3B
$11.8B
$12.6B
Total Liabilities
$95.8B
$99.1B
$85.2B
$1.0B
$1.3B
$102.3B
$90.9B
$107.0B
$155.8B
$195.0B
Current Liabilities
$85.0B
$69.7B
$59.7B
$962.0M
$1.1B
$94.0B
$85.8B
$96.0B
$130.4B
$164.2B
Borrowings
$49.2B
$50.7B
$38.4B
$292.0M
$415.0M
$33.8B
$13.5B
$20.0B
$46.8B
$75.8B
Other Liabilities
$46.6B
$48.4B
$46.8B
$729.0M
$850.0M
$68.5B
$77.4B
$86.9B
$109.1B
$119.1B
Equity
$829.0M
$830.0M
$830.0M
$11.0M
$11.0M
$832.0M
$833.0M
$834.0M
$834.0M
$818.0M
Reserves
$124.0B
$126.5B
$140.2B
$2.0B
$2.4B
$190.5B
$231.0B
$280.6B
$333.4B
$369.6B
For Dr. Reddy's Laboratories Ltd, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $32.1B; free cash flow was positive in 9 of 10 years; financing activities used $1.3B in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Operating Cash Flow
$21.5B
$18.0B
$28.7B
$29.8B
$35.7B
$28.1B
$58.9B
$45.4B
$46.4B
$56.6B
Investing Cash Flow
$-59.5B
$-25.9B
$-15.2B
$-11.0B
$-35.2B
$-45.4B
$-60.2B
$-67.7B
$-92.5B
$-95.1B
Financing Cash Flow
$4.9B
$-1.3B
$-2.1B
$-2.1B
$-2.5B
$-1.3B
$-1.9B
$-2.3B
$2.2B
$-1.3B
Net Cash Flow
$-1.1B
$-1.2B
$-314.0M
$-266.0M
$12.9B
$32.0M
$-9.1B
$1.3B
$7.5B
$-876.0M
Free Cash Flow
$-19.5B
$7.0B
$21.2B
$23.7B
$23.1B
$9.1B
$40.0B
$18.0B
$12.0B
$32.1B
Valuation & Return Ratios
Metric
Value
PEG Ratio
-0.73
EV / EBITDA
15.98
FCF Yield
1.46%
Quick Ratio
1.39
Interest Coverage
8.47
Return 1Y
-11.30%
Return 3Y
-4.73%
Return 5Y
0.09%
Dr. Reddy's Laboratories Ltd (RDY) financials — frequently asked questions
What is Dr. Reddy's Laboratories Ltd's annual revenue?
Dr. Reddy's Laboratories Ltd (RDY) reported annual revenue of $353.5B in its most recent fiscal year.
What is Dr. Reddy's Laboratories Ltd's net profit?
Dr. Reddy's Laboratories Ltd (RDY) reported net profit of $45.1B in its most recent fiscal year.
What is RDY EV/EBITDA?
Dr. Reddy's Laboratories Ltd's enterprise value to EBITDA (EV/EBITDA) ratio is 15.98.